Consistent with these studies, our scRNA-seq analysis reveals a significant decrease in tumor EMT and stemness (Myc Targets V1 signaling) following chemo/anti-LIF/anti-PD-L1 treatment (Figure 4b,e–h). The gene discussed is LIF; the disease is neoplasm.